Viewing Study NCT06506981



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06506981
Status: COMPLETED
Last Update Posted: None
First Post: 2024-07-10

Brief Title: Impact of Electrolyte Intake Sodium Phosphorus on the Growth of Premature Newborns
Sponsor: None
Organization: None

Study Overview

Official Title: Association Between Electrolyte Intake and Growth Trajectories in Premature Newborns a Retrospective Population-based Study Between January 2023 and December 2023 at the Regional Maternity Hospital of Nancy
Status: COMPLETED
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ELECTROGRO
Brief Summary: Extrauterine growth restriction EUGR is a common complication in the medical management of premature newborns The long-term consequences of EUGR are weight and height restriction metabolic disorders and neurodevelopmental disorders The main risk factor for EUGR is nutritional deficiency particularly protein and energy Additionally appropriate intakes of electrolytes particularly sodium and phosphorus are essential to promote harmonious growth Adequate sodium intake is essential to ensure satisfactory growth especially in premature babies due to their higher body water content Adequate phosphorus intake is also essential because of its involvement in the formation of lean mass with sufficient protein intake and in phosphocalcic metabolism

At the Regional University Maternity of Nancy parenteral and enteral nutrition prescriptions for each premature newborn are made using the Logipren prescription assistance software based on ESPGHAN recommendations Despite this theoretical security it seems that they are not strictly respected At the same time premature newborns typically show weight loss often greater than -1 z-score

The objective of this research is to study the impact of electrolyte intake sodium and phosphorus on growth trajectories and the incidence of EUGR in premature newborns discharged from the Nancy Maternity Hospital in 2023 The secondary criteria are to describe sodium phosphorus protein and calorie intake and compliance with ESPGHAN recommendations assess the true prevalence of stunting in our study population and the impact of meeting electrolyte intake recommendations on childrens growth trajectory taking into account protein and calorie intake
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None